Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
Susan Buchbinder(University of California, San Francisco), M. Anthony Moody(Duke University), David C. Montefiori(Duke University), Nicole Grunenberg(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Paul Goepfert(University of Maryland, Baltimore), Georgia D. Tomaras(National Institutes of Health), Harriet L. Robinson(GeoVax (United States)), Nicole Frahm(Fred Hutch Cancer Center), Guido Ferrari(Duke University), Brittany Sanchez(Fred Hutch Cancer Center), M. Juliana McElrath(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsey R. Baden(Brigham and Women's Hospital), Xuesong Yu(Fred Hutch Cancer Center), Kelly E. Seaton(International Vaccine Institute), Christine M. Hay(University of Rochester)
Cited by 33
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k